Clin2
NCT05737355Possibly a fitRecruiting

Test food product for cholesterol balance and lipid levels

Hyperlipidemias

Part of Hormones & metabolism clinical trials.

This trial tests whether ANKASCIN 568-P products can improve blood cholesterol levels (like LDL and HDL) in people with mild “lipid” (cholesterol/fat) imbalance. It may help by lowering “bad” cholesterol and improving balance, especially if you’re not taking cholesterol-lowering medicine right now.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
20 years and older
Study type
Interventional

Who can take part

  • You’re an adult (age 20 or older) and can communicate with the study team
  • Your BMI is between 18 and 35
  • Your recent blood tests show LDL cholesterol between 130 and 190 mg/dL
  • Your HDL cholesterol is below 50 mg/dL
  • You do not have major other serious conditions (like uncontrolled heart disease, cancer, diabetes, stroke, or significant liver/kidney problems)
  • You agree not to change your usual daily routine and eating habits on purpose during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05737342Recruiting
Test supplement to lower A1c and steady blood sugar

This trial studies ANKASCIN 568-P products to see if they can lower A1c (a blood sugar average) and help regulate blood glucose. It may help people with early blood sugar problems, but you must avoid diabetes medicines during the study.

Taipei
NCT07441317Not yet recruiting· Phase 3
Testing a new drug for stubborn high cholesterol

This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.

NCT07444086Not yet recruiting· Phase 3
A study of a new medicine for high cholesterol

This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.

NCT07230730Recruiting· Phase 3
Testing a new drug for high cholesterol

This trial tests a new medication called SHR-1918 for people with high cholesterol who are already on statins. The goal is to see if it can further lower cholesterol and improve health.

Hangzhou, Zhejiang
NCT07178769Recruiting
Testing a supplement for lowering cholesterol

This trial tests a nutritional supplement with bergamot, artichoke, and other natural ingredients to see if it can safely lower cholesterol in people with moderately high LDL. It may be an option for those not currently on other cholesterol treatments.

Madrid, Madrid
NCT07777003Not yet recruiting· Phase 1
Study of a new drug for mild high cholesterol

This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.

Hear when a new Hyperlipidemias trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.